Back to Search
Start Over
Incidence of upper tract urothelial carcinoma in Spain.
- Source :
-
Actas urologicas espanolas [Actas Urol Esp (Engl Ed)] 2020 Sep; Vol. 44 (7), pp. 512-518. Date of Electronic Publication: 2020 Jul 01. - Publication Year :
- 2020
-
Abstract
- Introduction and Objectives: The incidence of upper urinary tract tumors is currently unknown. The aim of this study is to determine the real incidence of upper tract urothelial carcinoma (UTUC) in Spain.<br />Material and Methods: A descriptive, prospective and multicenter epidemiological study was conducted in 31 Spanish facilities by means of the Platform for Multicenter Studies of the Spanish Association of Urology. Recruitment was opened from May 1 <superscript>st</superscript> , 2017 to April 30 <superscript>th</superscript> , 2018. The original database was exported directly from the electronic Data Collection Logbook on December 15 <superscript>th</superscript> , 2018, with a total of 404 cases registered (402 valid cases after depuration). Statistical analysis was performed using IBM SPSS software v 23 and EPIDAT v 3.4.<br />Results: The incidence adjusted to Spanish population from raw data was 3.27 cases per 100.000 inhabitants per year (2.93 - 3.61 95% CI) and 3,3 cases per 100.000 inhabitants per year (2.96-3.66 95%CI) when adjusted to European population by age. The mean age at diagnosis was 70 years, and 77% of patients were male. Thirty-four percent of patients had an incidental diagnosis. Tumors were most commonly located in the pyelocalyceal system (54%), followed by the distal ureter (22%). Prior ureteroscopy was performed in 114 patients: this technique modified the subsequent treatment indication in 58% of cases. Radical nephroureterectomy was performed in 311 patients. Kidney-sparing surgery was the elected treatment in 76 patients (20%). Complications were found in 69% of cases, most of them classified as Clavien 1 and 2 (86% of all complications). Postoperative mortality rate was 1.7%.<br />Conclusions: UTUC adjusted incidence rate in Spain is 3.27 and 3.3 in Europe. Prior URS modified the treatment indication in 18% of patients. We found a 69% complication rate and a 1.7% mortality rate.<br /> (Copyright © 2020 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
Details
- Language :
- English; Spanish; Castilian
- ISSN :
- 2173-5786
- Volume :
- 44
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Actas urologicas espanolas
- Publication Type :
- Academic Journal
- Accession number :
- 32622540
- Full Text :
- https://doi.org/10.1016/j.acuro.2020.03.007